InvestorsObserver
×
News Home

Is Agenus Inc (AGEN) a Winner in the Biotechnology Industry?

Tuesday, September 20, 2022 11:43 AM | InvestorsObserver Analysts

Mentioned in this article

Is Agenus Inc (AGEN) a Winner in the Biotechnology Industry?

Agenus Inc (AGEN) is around the top of the Biotechnology industry according to InvestorsObserver. AGEN received an overall rating of 65, which means that it scores higher than 65 percent of all stocks. Agenus Inc also achieved a score of 73 in the Biotechnology industry, putting it above 73 percent of Biotechnology stocks. Biotechnology is ranked 20 out of the 148 industries.

Overall Score - 65
AGEN has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on AGEN!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 65 would rank higher than 65 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Agenus Inc Stock Today?

Agenus Inc (AGEN) stock is trading at $2.29 as of 11:42 AM on Tuesday, Sep 20, a loss of -$0.02, or -0.87% from the previous closing price of $2.31. The stock has traded between $2.26 and $2.36 so far today. Volume today is below average. So far 401,532 shares have traded compared to average volume of 4,101,315 shares. Click Here to get the full Stock Report for Agenus Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App